Sanofi Multiple Sclerosis Drug Gets EU Approval
Sanofi said it received European Union approval for Cenrifki, a new multiple sclerosis medicine, after U.S. regulators rejected it.
Connecting Global Economies
Sanofi said it received European Union approval for Cenrifki, a new multiple sclerosis medicine, after U.S. regulators rejected it.